Literature DB >> 8698866

Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.

K Rebrin1, G M Steil, S D Mittelman, R N Bergman.   

Abstract

Suppression of hepatic glucose output (HGO) has been shown to be primarily mediated by peripheral rather than portal insulin concentrations; however, the mechanism by which peripheral insulin suppresses HGO has not yet been determined. Previous findings by our group indicated a strong correlation between free fatty acids (FFA) and HGO, suggesting that insulin suppression of HGO is mediated via suppression of lipolysis. To directly test the hypothesis that insulin suppression of HGO is causally linked to the suppression of adipose tissue lipolysis, we performed euglycemic-hyperinsulinemic glucose clamps in conscious dogs (n = 8) in which FFA were either allowed to fall or were prevented from falling with Liposyn plus heparin infusion (LI; 0.5 ml/min 20% Liposyn plus 25 U/min heparin with a 250 U prime). Endogenous insulin and glucagon were suppressed with somatostatin (1 microgram/min/kg), and insulin was infused at a rate of either 0.125 or 0.5 mU/min/kg. Two additional experiments were performed at the 0.5 mU/min/kg insulin dose: a double Liposyn infusion (2 x LI; 1.0 ml/min 20% Liposyn, heparin as above), and a glycerol infusion (19 mg/min). With the 0.125 mU/min/kg insulin infusion, FFA fell 40% and HGO fell 33%; preventing the fall in FFA with LI entirely prevented this decline in HGO. With 0.5 mU/min/kg insulin infusion, FFA levels fell 64% while HGO declined 62%. Preventing the fall in FFA at this higher insulin dose largely prevented the fall in HGO; however, steady state HGO still declined by 18%. Doubling the LI infusion did not further affect HGO, suggesting that the effect of FFA on HGO is saturable. Elevating plasma glycerol levels did not alter insulin's ability to suppress HGO. These data directly support the concept that insulin suppression of HGO is not direct, but rather is mediated via insulin suppression of adipose tissue lipolysis. Thus, resistance to insulin control of hepatic glucose production in obesity and/or non-insulin-dependent diabetes mellitus may reflect resistance of the adipocyte to insulin suppression of lipolysis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698866      PMCID: PMC507484          DOI: 10.1172/JCI118846

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

1.  Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects.

Authors:  G R Fulcher; M Walker; C Catalano; L Agius; K G Alberti
Journal:  Diabetes       Date:  1992-11       Impact factor: 9.461

2.  Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus.

Authors:  N Nurjhan; A Consoli; J Gerich
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

3.  Dynamics of hepatic and peripheral insulin effects suggest common rate-limiting step in vivo.

Authors:  D C Bradley; R A Poulin; R N Bergman
Journal:  Diabetes       Date:  1993-02       Impact factor: 9.461

4.  Mechanism of regulation of glucose production by lipolysis in humans.

Authors:  F Jahoor; S Klein; R Wolfe
Journal:  Am J Physiol       Date:  1992-03

5.  Glucagon does not increase plasma free fatty acid and glycerol concentrations in patients with noninsulin-dependent diabetes mellitus.

Authors:  C Y Jeng; W H Sheu; J B Jaspan; K S Polonsky; Y D Chen; G M Reaven
Journal:  J Clin Endocrinol Metab       Date:  1993-07       Impact factor: 5.958

6.  Regulation of free fatty acid metabolism by glucagon.

Authors:  M G Carlson; W L Snead; P J Campbell
Journal:  J Clin Endocrinol Metab       Date:  1993-07       Impact factor: 5.958

7.  Analysis of techniques to obtain plasma for measurement of levels of free fatty acids.

Authors:  A Zambon; S I Hashimoto; J D Brunzell
Journal:  J Lipid Res       Date:  1993-06       Impact factor: 5.922

8.  Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study.

Authors:  I Magnusson; D L Rothman; L D Katz; R G Shulman; G I Shulman
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

9.  Enzyme immunoassay for intact human insulin in serum or plasma.

Authors:  L Andersen; B Dinesen; P N Jørgensen; F Poulsen; M E Røder
Journal:  Clin Chem       Date:  1993-04       Impact factor: 8.327

10.  Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs.

Authors:  A Giacca; S J Fisher; Z Q Shi; R Gupta; H L Lickley; M Vranic
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

View more
  70 in total

Review 1.  Insulin's effect on glucose production: direct or indirect?

Authors:  Eugene J Barrett
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

Review 2.  The role of the liver in type 2 diabetes.

Authors:  Peter Staehr; Ole Hother-Nielsen; Henning Beck-Nielsen
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

3.  Bolus Estimation--Rethinking the Effect of Meal Fat Content.

Authors:  Srinivas Laxminarayan; Jaques Reifman; Stephanie S Edwards; Howard Wolpert; Garry M Steil
Journal:  Diabetes Technol Ther       Date:  2015-08-13       Impact factor: 6.118

4.  Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action.

Authors:  Haruka Okamoto; Silvana Obici; Domenico Accili; Luciano Rossetti
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

5.  Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes.

Authors:  Rachel J Perry; João-Paulo G Camporez; Romy Kursawe; Paul M Titchenell; Dongyan Zhang; Curtis J Perry; Michael J Jurczak; Abulizi Abudukadier; Myoung Sook Han; Xian-Man Zhang; Hai-Bin Ruan; Xiaoyong Yang; Sonia Caprio; Susan M Kaech; Hei Sook Sul; Morris J Birnbaum; Roger J Davis; Gary W Cline; Kitt Falk Petersen; Gerald I Shulman
Journal:  Cell       Date:  2015-02-05       Impact factor: 41.582

6.  Brain insulin controls adipose tissue lipolysis and lipogenesis.

Authors:  Thomas Scherer; James O'Hare; Kelly Diggs-Andrews; Martina Schweiger; Bob Cheng; Claudia Lindtner; Elizabeth Zielinski; Prashant Vempati; Kai Su; Shveta Dighe; Thomas Milsom; Michelle Puchowicz; Ludger Scheja; Rudolf Zechner; Simon J Fisher; Stephen F Previs; Christoph Buettner
Journal:  Cell Metab       Date:  2011-02-02       Impact factor: 27.287

7.  Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.

Authors:  M Mevorach; A Giacca; Y Aharon; M Hawkins; H Shamoon; L Rossetti
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

Review 8.  Regulation of Glucose Production in the Pathogenesis of Type 2 Diabetes.

Authors:  Ashot Sargsyan; Mark A Herman
Journal:  Curr Diab Rep       Date:  2019-08-03       Impact factor: 4.810

9.  Burst-like control of lipolysis by the sympathetic nervous system in vivo.

Authors:  Katrin Hücking; Marianthe Hamilton-Wessler; Martin Ellmerer; Richard N Bergman
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 10.  Mechanisms of improved glucose handling after metabolic surgery: the big 6.

Authors:  Rebecca L Paszkiewicz; Richard N Bergman
Journal:  Surg Obes Relat Dis       Date:  2016-03-14       Impact factor: 4.734

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.